PHARMACEUTICAL FORMULATION FOR ADMINISTRATION BY INHALATION COMPRISING AN ANDROSTANE DERIVATIVE AND A BETA-2-ADRENORECEPTOR FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC CONDITIONS

Details for Australian Patent Application No. 2003207016 (hide)

Owner GLAXO GROUP LIMITED

Inventors BIGGADIKE, Keith

Pub. Number AU-A-2003207016

PCT Number PCT/GB03/00467

PCT Pub. Number WO2003/066036

Priority 10/066,836 04.02.02 US

Filing date 4 February 2003

Wipo publication date 2 September 2003

International Classifications

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 011/06 Drugs for disorders of the respiratory system

A61K 031/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 10/066,836 04.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-A-2003207016

21 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207017-CAST BRAKE DISC

2003207015-ANTENNA ARRAY CALIBRATION